TrialX
Image

Preoperative Estimation Of Disc Herniation Recurrence In Patients With Lumbar Disc Herniation

Preoperative Estimation Of Disc Herniation Recurrence In Patients With Lumbar Disc Herniation

Recruiting
18-60 years
All
Phase N/A

Overview

This study will be conducted at Research Institute of Traumatology and Orthopedics (NRITO) n.a. Ya.L.Tsivyan, Novosibirsk, Russia.

The current study is prospective observational study to evaluate the efficacy of preoperative estimation of disc herniation recurrence among patients with lumbar disc herniation using predictive mathematical model at terms 3 years postoperatively .

It is expected to enroll 350 patients aged 18-70 with lumbar disc herniation. Risk estimation of disc herniation recurrence will be evaluated preoperatively, then patient will undergo conventional microdiscectomy. Postoperative eximanation will include Visits every 6-months during 3 years to evaluate clinical outcomes.

Eligibility

Inclusion Criteria:

  • Age 18 to 60 years;

Single level lumbar disc herniation with neural compression confirmed on MRI at one level of L4-L5 or L5-S1;

  1. Radicular leg pain with or without back pain;
  2. Symptoms persisting for at least four weeks prior to surgery;
  3. Given written Informed Consent;
  4. Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements;
  5. Visual Analogue Scale score at least 40/100 at baseline.

Exclusion Criteria:

  1. More than one symptomatic level requiring multilevel surgical decompression
  2. Stenosis any etiology at the same level;
  3. Spondylolisthesis any etiology at the same level;
  4. Prior lumbar spinal surgery at any level;
  5. Other non-degenerative spinal conditions (e.g. infectious, traumatic, metabolic, inflammatory, neoplastic, structural or other pathology) that may have an impact on subject safety, wellbeing or the intent and conduct of the study
  6. Concurrent participation in another clinical study that may confound study results.

Study details
    Slipped disc

NCT04254250

Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.